traumatic acid : A monounsaturated straight-chain dicarboxylic acid with the double bond at C-2; a plant wound-healing hormone. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 5283028 |
| CHEMBL ID | 470062 |
| CHEBI ID | 545687 |
| SCHEMBL ID | 38779 |
| MeSH ID | M0496525 |
| Synonym |
|---|
| LS-14128 |
| 2-dodecenedioic acid |
| nsc-8125 |
| 124-00-5 |
| nsc8125 |
| 1-decene-1,10-dicarboxylic acid |
| dodec-2-enedioic acid |
| (2e)-dodecenedioic acid |
| dodecanedioic acid-2-ene |
| 6402-36-4 |
| (e)-dodec-2-enedioic acid |
| trans-2-dodecenedioic acid |
| LMFA01170002 |
| 2e-dodecenedioic acid |
| trans-traumatic acid |
| traumatic acid |
| trans-2-dodecene-1,12-dioic acid |
| D0029 |
| CHEMBL470062 |
| (2e)-dodec-2-enedioic acid |
| CHEBI:545687 , |
| unii-l7nd24937h |
| 2-dodecene-1,12-dicarboxylic acid |
| einecs 229-019-4 |
| nsc 8125 |
| l7nd24937h , |
| SCHEMBL38779 |
| fema no. 4944 |
| traumatic acid [mi] |
| trau-matic acid |
| traumatic acid for prostaglandin 99% |
| W-204239 |
| trans-2-dodecene-dioic acid |
| (2e)-2-dodecenedioic acid # |
| 2-dodecenedioic acid, (e)- |
| HMS3649M22 |
| 2-dodecenedioic acid, (2e)- |
| AKOS028109062 |
| mfcd00004443 |
| trans-traumatate |
| trans-2-dodecenedioate |
| dodec-2c-enedioate |
| dodec-2t-enedioic acid |
| (z)-2-dodecenedioic acid |
| 2-dodecendioate |
| dodec-2t-enedioate |
| 2e-dodecenedioate |
| dodec-2c-enedioic acid |
| 2-dodecendioic acid |
| (z)-2-dodecenedioate |
| 2-dodecenedioate |
| dodec-2-enedioate |
| traumatate |
| DTXSID00863778 |
| HY-119358 |
| SR-01000946624-1 |
| sr-01000946624 |
| Q7835820 |
| traumaticacid |
| 2(e)-dodecenedioic acid |
| CS-0067597 |
| S6163 |
Traumatic acid (TA) is a plant hormone (cytokinin) that in terms of chemical structure belongs to the group of fatty acids derivatives.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Traumatic acid (TA) is a potent wound-healing agent in plants, considered an antioxidant food ingredient." | ( Traumatic acid inhibits ACSL4 associated lipid accumulation in adipocytes to attenuate high-fat diet-induced obesity. Dong, X; Gao, J; Guo, X; Peng, Z; Wang, X; Xu, L; Xu, Z; Zhang, L; Zhang, Z; Zhao, J, 2023) | 3.07 |
| "Traumatic acid (TA) is a plant hormone (cytokinin) that in terms of chemical structure belongs to the group of fatty acids derivatives. " | ( Traumatic Acid Reduces Oxidative Stress and Enhances Collagen Biosynthesis in Cultured Human Skin Fibroblasts. Czerpak, R; Jabłońska-Trypuć, A; Pankiewicz, W, 2016) | 3.32 |
| Role | Description |
|---|---|
| plant hormone | A plant growth regulator that modulates the formation of stems, leaves and flowers, as well as the development and ripening of fruit. The term includes endogenous and non-endogenous compounds (e.g. active compounds produced by bacteria on the leaf surface) as well as semi-synthetic and fully synthetic compounds. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| dicarboxylic acid | Any carboxylic acid containing two carboxy groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (38.72) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (9.09%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (90.91%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||